These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8038308)

  • 1. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation.
    Pauksen K; Hammarström V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Magnius L; Simonsson B
    Clin Infect Dis; 1994 Apr; 18(4):547-52. PubMed ID: 8038308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to immunization against polio after allogeneic marrow transplantation.
    Ljungman P; Duraj V; Magnius L
    Bone Marrow Transplant; 1991 Feb; 7(2):89-93. PubMed ID: 1646664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to polio vaccination in bone marrow transplant recipients.
    Engelhard D; Handsher R; Naparstek E; Hardan I; Strauss N; Aker M; Or R; Baciu H; Slavin S
    Bone Marrow Transplant; 1991 Oct; 8(4):295-300. PubMed ID: 1661633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT.
    Parkkali T; Stenvik M; Ruutu T; Hovi T; Volin L; Ruutu P
    Bone Marrow Transplant; 1997 Oct; 20(8):663-8. PubMed ID: 9383230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content.
    Mellander L; Böttiger M; Hanson LA; Taranger J; Carlsson B
    Acta Paediatr; 1993; 82(6-7):552-6. PubMed ID: 8393360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological control over the state of immunity to the poliomyelitis virus in children].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN; Stepanova GS
    Vopr Virusol; 1974; (4):418-23. PubMed ID: 4373926
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming after a fractional dose of inactivated poliovirus vaccine.
    Resik S; Tejeda A; Sutter RW; Diaz M; Sarmiento L; Alemañi N; Garcia G; Fonseca M; Hung LH; Kahn AL; Burton A; Landaverde JM; Aylward RB
    N Engl J Med; 2013 Jan; 368(5):416-24. PubMed ID: 23363495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional doses of inactivated poliovirus vaccine in Oman.
    Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
    N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence after primary immunization with trivalent oral poliovirus vaccine.
    Krugman RD; Hardy GE; Sellers C; Parkman PD; Witte JJ; Meyer BC; Meyer HM
    Pediatrics; 1977 Jul; 60(1):80-2. PubMed ID: 195265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.
    Bockstal V; Tiemessen MM; Achterberg R; Van Wordragen C; Knaapen AM; Serroyen J; Marissen WE; Schuitemaker H; Zahn R
    Vaccine; 2018 Nov; 36(46):6979-6987. PubMed ID: 30314910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
    Embree J; Law B; Voloshen T; Tomovici A
    Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to polioviruses and tetanus after bone marrow transplantation in children.
    Pezzini C; Limonta M; Rovelli A; Uderzo C; Locasciulli A; Maglia O; Masera G; Barbi M; Pozzi A; Luraschi C
    Pediatr Hematol Oncol; 1994; 11(3):331-6. PubMed ID: 8060817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimmunization after blood or marrow stem cell transplantation.
    Singhal S; Mehta J
    Bone Marrow Transplant; 1999 Apr; 23(7):637-46. PubMed ID: 10218839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.